Transfusion

Therapy in Pediatric Patients

Therapy in Pediatric Patients

Iron Overload and Iron Chelation Therapy in Pediatric Patients

Elliott Vichinsky

US Hematology, 2009;2(1):64-7

Safety of Deferasirox

Safety of Deferasirox

Efficacy and Safety of Deferasirox

Maria Domenica Cappellini, Laura Zanaboni

US Hematology, 2009;2(1):68-79

Anti-ABO Antibodies

Anti-ABO Antibodies

Platelet Activation Following Exposure to Anti-ABO Antibodies— An In Vitro Study

Majed A Refaai, Kelly F Henrichs, Sherry L Spinelli, Richard P Phipps, Edward Masel, Brian H Smith, Charles W Francis, Neil Blumberg

US Oncology & Hematology, 2011;7(1):72-4

Iron Chelation Therapy

Iron Chelation Therapy

Overview of Current Treatment Regimens in Iron Chelation Therapy

Aryeh shander, Joseph D Sweeney

US Hematology, 2009;2(1):56-9

Editor's choice

Iron Chelation Therapy
Should Patients with Myelodysplastic Syndromes Undergo Iron Chelation Therapy? New Data Answering the Question
Stuart L Goldberg et al.
Oncology & Hematology Review, 2009;2(1):60-63

Latest Articles

Platelet Activation Following Exposure to Anti-ABO Antibodies— An In Vitro Study
Majed A Refaai, Kelly F Henrichs, Sherry L Spinelli, Richard P Phipps, Edward Masel, Brian H Smith, Charles W Francis, Neil Blumberg
Overview of Current Treatment Regimens in Iron Chelation Therapy
Aryeh shander, Joseph D Sweeney
Efficacy and Safety of Deferasirox
Maria Domenica Cappellini, Laura Zanaboni
Neutralising Pathogens in Blood in Developing Countries – Thinking Outside the Screening Box
Gadi Borkow, Abdoulaye Doucoure
The Harmful Effects of Iron Overload in Patients with Myelodysplastic Syndrome
Andrea Toma, François Dreyfus
all articles >
close

This content is copyright protected

However, if you would like to share the information on this webpage, you may use the headline and link below:

Transfusion

Read more: Transfusion